Equity |
12 Months Ended |
|---|---|
Jun. 30, 2021 | |
| Stockholders' Equity Note [Abstract] | |
| Equity |
Note 8 – Equity In fiscal years 2021 and 2020, 97,250,000 and 642,857 shares were awarded under the Stock Plan (see Note 13). In fiscal year 2021, the Company issued 57,500,000 common shares as consideration for convertible notes. In fiscal year 2020, the Company issued 525,000 common shares as consideration for convertible notes. There were no preferred shares issued in fiscal year 2021. In fiscal year 2020, the Company issued 500,000 shares of Series E Preferred Stock to an investor that converts into 1,190,476 shares of common stock as consideration for a convertible note. During the years ended June 30, 2021 and 2020, the Company issued 105,800,000 and 7,619,912 common shares for professional consulting services, respectively. The shares were valued at $2,767,970 and $2,020,150 upon issuance, for the years ended June 30, 2021 and 2020, respectively. In fiscal year 2021, the Company issued 50,000,000 shares as collateral for the line of credit. There was no such transaction in fiscal year 2020. During fiscal year 2021, investors exercised warrants in exchange for 249,792,217 common shares in cashless transactions. During fiscal year 2020, investors exercised warrants in exchange for 32,052,654 common shares in cashless transactions. See the capital structure section in Note 1 for disclosure of the equity components included in the Company's consolidated financial statements as well as the consolidated statements of stockholders' deficit for additional equity transactions that occurred as of and for the years ended June 30, 2021 and 2020. |